0001474064-13-000002.txt : 20130107
0001474064-13-000002.hdr.sgml : 20130107
20130107160919
ACCESSION NUMBER: 0001474064-13-000002
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130107
FILED AS OF DATE: 20130107
DATE AS OF CHANGE: 20130107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nader Francois
CENTRAL INDEX KEY: 0001365343
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 13515403
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4/A
1
edgar.xml
PRIMARY DOCUMENT
X0306
4/A
2013-01-07
2012-12-26
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001365343
Nader Francois
550 HILLS DRIVE
BEDMINSTER
NJ
07921
0
1
0
0
President & CEO
Common Stock
2012-12-21
4
J
0
30450
A
165111
D
On February 7, 2012, the reporting person was awarded 60,900 restricted stock units under the 2005 Omnibus Incentive Plan with each restricted stock unit representing a contingent right to receive one share of NPS Pharmaceuticals, Inc.'s (the "Company") common stock upon the satisfaction of the following performance criteria: (i) one half of the restricted stock units will vest upon FDA approval of GATTEX and (ii) one half will vest upon FDA approval of NATPARA, with no shares being able to be earned after July 31, 2014. The FDA approved GATTEX, resulting in vesting of 30,450 restricted stock units and the payment to the reporting person of 30,450 shares of the Company's common stock on December 21, 2012.
The vesting of these restricted stock units was omitted from the reporting person's Form 4 filed on December 26, 2012.
Includes 1,043 shares acquired under the Company's employee stock purchase plan on March 30, 2012 and 928 shares acquired under the Company's employee stock purchase plan on September 30, 2012.
/s/ Francois Nader, by Edward Stratemeier as Attorney-In-Fact
2013-01-07